Return to Article Details
TOPICAL CLOTRIMAZOLE 1% (CANDID) IN THE MANAGEMENT OF ACUTE PSEUDOMEMBRANOUS ORAL CANDIDIASIS IN NEONATES: CLINICAL EVIDENCE AND A PROSPECTIVE EVALUATION FRAMEWORK